Although there has been a signiflcant decline in the incidence and mortality of invasive cervical cancer in the last 50 years (1), there has been an increase in the incidence of cervical intraepithelial neoplasia (CIN), reflecting both improved screening and detection methods and a true increase in the incidence of precancerous lesions of the cervix (2). The mortality of cervical cancer is estimated to rise by 20% in the years 2000-2004 unless improvements are made in current screening and detection techniques (3). Initial screening for cervical cancer and CIN requires a cytologic smear. A false-negative error rate of 20-30% is associated with this technique due to insufficient sampling and reading error (4). An abnormal Papanicolaou (Pap) smear is followed by colposcopy, biopsy, histologic evaluation, and diagnosis (5). The accuracy of colposcopy in differentiating human papilloma viral (HPV) infection and CIN from normal and inflammatory cervical tissues is variable and limited even in experienced hands [average sensitivity, specificity, and positive predictive value (6) of 94% ? 14%, 51% ? 24%, and 83% ? 15%, respectively (7)]. A method to improve the performance of colposcopy could save patients from multiple biopsies, allow more effective wide-scale diagnosis, and potentially permit combined diagnosis and treatment in a single visit.
Spectroscopic methods show potential for differentiating cervical neoplasia from the normal cervix (8-11). At 330-nm
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. ?1734 solely to indicate this fact. excitation, the steady-state fluorescence of abnormal tissue is significantly weaker than that of normal tissue from the same patient in vitro (8) . An algorithm to identify histologic abnormality based on comparison of peak intensities of histologically normal and abnormal biopsies from the same patient had a sensitivity, specificity, and positive predictive value of 75%, 88%, and 86%, respectively (8) .
Fluorescence spectra have been measured in vivo to detect neoplastic tissues in a variety of organ systems (12-14). Lam et al. (12) demonstrated that the sensitivity of fluorescence bronchoscopy is greater than conventional bronchoscopy. Autofluorescence has also been used to distinguish adenomatous polyps from normal colon and hyperplastic polyps in vivo (13, 14) . To quantitate spectral changes, Schomacker (14) fit fluorescence spectra of colonic tissue (337-nm excitation) to a linear combination of three fluorescent components: collagen, reduced nicotinamide adenine dinucleotide (NADH), and flavin adenine dinucleotide (FAD). Good fits were obtained except over 400-440 nm and 520-600 nm, where hemoglobin reabsorption is greatest. A decrease in collagen fluorescence and an increase in NADH fluorescence and hemoglobin reabsorption were seen as tissue progresses from normal to adenocarcinoma.
These studies indicate the potential of fluorescence to diagnose neoplasia. Algorithms are implemented in software and can potentially place automated cancer detection in the hands of less experienced practitioners. A quantitative analysis of fluorescence spectra to obtain contributions of individual tissue components can provide insight into biochemical changes associated with neoplasia.
On the basis of the spectroscopic differences between normal, nonneoplastic abnormal, and neoplastic cervical tissue in vitro and the capability to measure tissue fluorescence rapidly in vivo, we designed a study to measure autofluorescence of the intact cervix at colposcopy. Our goal was to develop and evaluate the performance of a spectroscopic method to differentiate CIN from normal and nonneoplastic abnormal cervical tissues. A preliminary analysis of fluorescence data acquired in vivo from 28 patients indicated that peak fluorescence intensities of histologically abnormal tissues are statistically less than that of colposcopically normal tissues in the same patient (15). In addition, spectral line shapes are statistically different between 400 and 450 nm. An algorithm was developed to differentiate histologic abnormality from colposcopically normal tissues with a high sensitivity, specificity, and positive predictive value (15). However, this preliminary analysis had two important limitations: clinically, the differential diagnosis of CIN and HPV infection is needed to determine if therapy is required. Furthermore, it is necessary to understand the biochemical and morphologic basis of the spectroscopic algorithms to appreciate additional informaAbbreviations: CIN, cervical intraepithelial neoplasia; HPV, human papilloma virus. ?To whom reprint requests should be addressed. tion that may be available and to predict clinical conditions in which its diagnostic ability may be limited. This paper describes a clinical study and data analysis method to address these limitations. A two-stage spectroscopic algorithm to diagnose histologic abnormality and differentially diagnose CIN at colposcopy is presented. Spectra acquired in vivo are compared to those reported in vitro (8) four patients, the fluorescence intensities of histologically abnormal tissues are lower than those of corresponding colposcopically normal tissues. Fig. 1 indicates that the fluorescence intensities of normal tissues vary by more than a factor of two from patient to patient, while within a single patient fluorescence intensities of normal areas vary by <15%. Evaluation of abnormal tissue spectra from the same patient indicates that tissues with HPV infection are less fluorescent than tissues with chronic inflammation (Fig. 1A) . Tissues with dysplastic changes have a lower fluorescence intensity than tissues with inflammation or HPV infection (Fig. 1C) , with CIN III exhibiting the weakest fluorescence intensity (Fig. 1D) . A two-dimensional scatter plot of the slope from 420 to 440 nm versus the relative peak fluorescence intensity of each site is shown in Fig. 2 . The relative peak fluorescence intensities of colposcopically normal samples are close to 1 while the relative peak fluorescence intensities of histologically abnormal sites are <1 on average. The slope over 420-440 nm of abnormal tissue spectra is greater than that of normal tissue spectra, which in part reflects the longer peak emission wavelength of abnormal tissue fluorescence. Sites that lie below the decision line in Fig. 2 are classified as normal and those that lie above the line are classified as abnormal. This algorithm diagnoses histologic abnormality with a sensitivity, specificity, and positive predictive value of 92%, 90%, and 88%, respectively. Three of the four abnormal samples misclassified have HPV infection and the fourth has CIN I. The spectroscopic algorithm classifies 9% of the colposcopically normal tissues as abnormal, comparable to the average falsenegative rate (12% ? 10%) for colposcopy (7).
A spectroscopic algorithm capable of differentiating CIN from HPV infection or inflammation would be of greater clinical value. A relationship, as noted in Fig. 1 B-D, was observed between the peak emission wavelengths of CIN spectra and their corresponding normal spectra. This relationship was not observed in the spectra of samples with HPV infection and inflammation. Hence, a simple diagnostic algorithm based on peak emission wavelengths can be defined. However, because the emission peaks are broad, these values can be significantly shifted by noise. Less sensitive to noise, but still related to peak emission wavelength, is the slope of the spectrum over the peak emission wavelength range. The peak emission wavelength of normal tissues can be characterized by the slope of the spectrum from 420 to 440 nm. Normal spectra with a small positive slope value indicate a peak near 442 nm, while those with a large positive slope value correspond to a peak near 453 nm. Similarly, the peak emission wavelength of abnormal spectra can be represented by the slope from 440 to 460 nm. A negative slope indicates a peak near 444 nm, a small positive or negative slope value indicates a peak near 454 nm, and a large positive slope corresponds to a peak emission wavelength near 463-470 nm.
The relationship between the peak emission wavelength of the abnormal spectrum and normal spectra from the same patient is mapped as a two-dimensional scatter plot in Fig. 3 , where the abscissa corresponds to the slope of the abnormal spectrum over the wavelength range 440-460 nm and the ordinate represents the average slope of normal spectra from the same patient over the wavelength range 420-440 nm. An algorithm to differentiate tissues with CIN from tissues with HPV infection or inflammation is represented by the decision line in Fig. 3, chosen to Fig. 4 compares measured and calculated fluorescence spectra (Eq. 1) for typical normal, HPV infection, and CIN II from the same patient. Residual differences are small and typical for all patients. Absolute contributions of tissue chromophores were determined from the average spectrum from each cervical site. Interpatient variations in spectra could not be attributed to variations in a single chromophore; therefore, to identify differences in chromophore contribution as tissue progresses from normal to abnormal within a patient, absolute contributions of chromophores were divided by the average contribution of that chromophore to normal spectra from the same patient (normalized absolute chromophore contribution). Fig. 5 A and B show the normalized absolute collagen and oxyhemoglobin contributions for all cervical sites. The absolute contribution of collagen fluorescence decreases and the contribution of oxyhemoglobin attenuation increases as tissue progresses from normal to abnormal in the same patient.
Absolute chromophore contributions reflect changes in both the intensity and shape of the fluorescence spectrum. Changes in the shape of the spectrum can be independently assessed by calculating the relative contribution of a chromophore to the spectrum. Relative contribution can be calculated by normalizing the measured spectrum to a peak intensity of 1 prior to fitting to Eq. 1. (Table 1) . The algorithm developed for identification of histologic abnormality in vivo relies on both intensity and line-shape information. When this algorithm was applied to data collected in vitro, the sensitivity and positive predictive values dropped significantly (Table 1) , confirming the limitations of in vitro studies for providing information about cervical tissue fluorescence line shape near 340-nm excitation.
Several hypotheses to relate differences in fluorescence spectra of normal and abnormal cervix to morphologic and biochemical differences can be developed from the least squares fit results. The squamous epithelium of the normal ectocervix has an underlying stroma that is composed mainly of collagen fibers (5). Usually neoplasia is associated with thickening of the epithelium. Hence, higher grades of neoplasia may correlate with decreased collagen fluorescence, as illustrated in Fig. SA (13, 14, 21) . The results of the least squares fit also demonstrate that the contribution of oxyhemoglobin appears to correlate with degree of abnormality (Fig. SB) . Tissues with severe grades of CIN exhibit the greatest vascularity (2) . No simple correlations between the contribution of a single chromophore and the algorithm parameters could be identified; however, the results of the least squares fit can be used to develop a qualitative understanding of these algorithms. The algorithm, which differentiates histologically abnormal and colposcopically normal tissue (Fig. 2) , is based on a drop in relative peak fluorescence intensity and a red shift in the peak emission wavelength as tissues become abnormal. The drop in relative peak intensity is consistent with both the drop in normalized absolute contribution of collagen fluorescence and the increase in normalized absolute contribution of oxyhemoglobin attenuation. The red shift in the peak emission wavelength is consistent with the increase in the normalized absolute contribution of oxyhemoglobin attenuation and the increase in normalized relative contribution of NAD(P)H fluorescence. The algorithm in Fig. 3 is based on the increased red shift of CIN spectra relative to normal spectra from the same patient. This is consistent with Fig. SC, which demonstrates that an increase in normalized relative contribution of NAD(P)H is most prominent in samples with CIN.
Interpatient variation could not be attributed to a single constituent but may be due to the heterogeneity in the depth distribution of the different chromophores. Our study included data from samples with multiple diagnoses. For instance, tissues were classified as CIN, even if they contained only minute localized lesions. As an area 1 mm in diameter was interrogated by the probe, small localized lesions may have different fluorescence spectra. The feasibility of differentiating samples with single histologic abnormalities from Future studies must also address potential limitations of algorithms presented here, which require colposcopic identification of normal tissue in each patient prior to diagnosis of histologic abnormality and CIN. Specifically, multiple sites should be spectroscopically examined on the cervix simultaneously prior to treatment with the loop electrosurgical procedure so that histologic evaluation of the excised normal and abnormal tissues can then be correlated with spectroscopic signals. The additional histologic information available from normal sites will enable evaluation of spectroscopic algorithms designed to automate detection of normal tissue. Furthermore, simultaneous interrogation of multiple sites on the cervix will allow for the evaluation of the effects of acetic acid on tissue spectra acquired prior to and at variable time intervals following the application of variable amounts of acetic acid. Finally, this protocol can be used to determine whether the sensitivity and specificity of spectroscopic diagnosis as represented here are limited by the use of colposcopy to initially identify normal and abnormal tissues.
